Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
BIOBank cortico-cancellous bone powder
- Development stage
- Unknown
- Lead developer
- Biobank
- Administration
- Topical
01
Overview
BIOBank cortico-cancellous bone powder is an allogeneic bone graft product developed by BIOBank, a French tissue bank authorized by ANSM. It consists of a 50/50 mixture of human cancellous and cortical bone particles sourced from the femoral heads of living donors. The bone tissue is processed using the proprietary Supercrit® process, which employs supercritical CO2 for delipidization and viral inactivation while preserving the structural and biomechanical properties of the graft. Indicated for bone regeneration in maxillofacial, oral, and dental surgery, the product acts as an osteoconductive scaffold. The cortical component ensures slower resorption compared to pure cancellous bone, providing prolonged stability for guided bone regeneration (GBR) and pre-implant bone augmentation.
- Brand names
- BIOBank cortico-cancellous bone powder
- Other names
- BIOBank allogeneic bone powderBIOBank bone powder
Beyond the preview
Go deeper on BIOBank cortico-cancellous bone powder.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on BIOBank cortico-cancellous bone powder.